{
  "Sold as": "AL-LAD",
  "Expected to be": "Not Specified",
  "Lab Comments": "Not Available",
  "Warning": "Analyzed by MDA Basecamp, a drug checking group based in Innsbruck, Austria. MDA Basecamp issued a warning because this blotter contains a drug other than the one it was represented as.",
  "Image": "6377.jpg",
  "table data left": {
    "ID": "6377",
    "Name": "AL-LAD",
    "Other Names": "Trip; Blotter",
    "HPLC:The HPLC Lab Test": "",
    "list_4": [
      "5-fluoro-ADB \n\n\n: 1 \n\n5-fluoro-ADB  aka cannabinoid; 5-F-ADB; 5FADB",
      "AL-LAD\n\n\n: 1 \n\nAL-LAD aka 6-allyl-6-nor-lysergic acid diethylamide; 6-NORLYSERGAMIDE; TIHKAL #1",
      "3-Fluorophenmetrazine\n\n\n: trace \n\n3-Fluorophenmetrazine aka 3-FPM, 3F-Phenmetrazine",
      "4-Methylmethcathinone\n\n\n: trace \n\n4-Methylmethcathinone aka Mephedrone, 4-MMC, 4-MMC, Meow, M-Cat, 2-Methylamino-1-p-tolylpropan-1-one",
      "ALD-52\n\n\n: trace \n\nALD-52 aka 1-Acetyl-N,N-diethyllysergamide"
    ]
  },
  "table data right": {
    "Test Date": "Jun 22, 2018",
    "Pub. Date": "Jun 29, 2018",
    "Src Location": "Innsbruck, \nAustria",
    "Submitter Loc": "Innsbruck, --Austria",
    "Color": "White / Gray",
    "Size": "-",
    "Data Source": "Drogenarbeit Z6",
    "Tested by": "GMI",
    "Lab's ID": "MB:201806-04"
  }
}